MUMBAI, India, June 30 -- Intellectual Property India has published a patent application (202647076036 A) filed by Aurigene Oncology Limited on June 19, 2026, for Macrocyclic Compounds As Kif18a Inhibitors.
Inventors include Abbineni, Chandrasekhar; Kadam, Vijay; Sengupta, Sandip; Samajdar, Susanta; Simonovich, Scott; Gillespie, Paul; M. Green, Evan; and Sanders, John.
The application for the patent was published on June 26, 2026, under issue no. 26/2026.
Abstract: The present disclosure provides macrocyclic compounds of formula (I), which are therapeutically useful as KIF18A inhibitors.(I) These compounds are useful in the treatment and/or prevention of diseases and/or disorders responsive to the inhibition of KIF18A activity. Compounds of the present disclosure are especially useful for treating cancer. The present disclosure also provides processes for the preparation of compounds of formula (I), as well as pharmaceutical formulations comprising at least one compound of formula (I) or a pharmaceutically acceptable salt or a stereoisomer thereof.
Disclaimer: Curated by HT Syndication.
